BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 24079479)

  • 1. Effect of bone-marrow-derived mesenchymal stem cells on high-potential hepatocellular carcinoma in mouse models: an intervention study.
    Li T; Song B; Du X; Wei Z; Huo T
    Eur J Med Res; 2013 Sep; 18(1):34. PubMed ID: 24079479
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of transforming growth factor β-1 infected human bone marrow mesenchymal stem cells on high- and low-metastatic potential hepatocellular carcinoma.
    Li T; Zhao S; Song B; Wei Z; Lu G; Zhou J; Huo T
    Eur J Med Res; 2015 May; 20(1):56. PubMed ID: 26003220
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of CCR1 gene overexpression on the migration of bone marrow - derived mesenchymal stem cells towards hepatocellular carcinoma].
    Gao Y; Huang XL; Zhang L; Deng L; Yin AH; Sun BC; Lu S
    Zhonghua Gan Zang Bing Za Zhi; 2017 May; 25(5):354-359. PubMed ID: 28763842
    [No Abstract]   [Full Text] [Related]  

  • 4. Hepatocellular carcinoma cells and their fibrotic microenvironment modulate bone marrow-derived mesenchymal stromal cell migration in vitro and in vivo.
    Garcia MG; Bayo J; Bolontrade MF; Sganga L; Malvicini M; Alaniz L; Aquino JB; Fiore E; Rizzo MM; Rodriguez A; Lorenti A; Andriani O; Podhajcer O; Mazzolini G
    Mol Pharm; 2011 Oct; 8(5):1538-48. PubMed ID: 21770423
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnetic Resonance Gd-RGD Imaging Study of Hepatocellular Carcinoma with High and Low Metastatic Potential before and after Human Bone Marrow-derived Mesenchymal Stem Cell Intervention.
    Li TR; Yu MH; Huang XB; Yang ZJ; Lu GM; Li YJ
    Chin Med J (Engl); 2017 Nov; 130(21):2591-2600. PubMed ID: 29067958
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemokine CCL15 Mediates Migration of Human Bone Marrow-Derived Mesenchymal Stem Cells Toward Hepatocellular Carcinoma.
    Gao Y; Zhou Z; Lu S; Huang X; Zhang C; Jiang R; Yao A; Sun B; Wang X
    Stem Cells; 2016 Apr; 34(4):1112-22. PubMed ID: 26763650
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human mesenchymal stem cells promote tumor growth via MAPK pathway and metastasis by epithelial mesenchymal transition and integrin α5 in hepatocellular carcinoma.
    Chen J; Ji T; Wu D; Jiang S; Zhao J; Lin H; Cai X
    Cell Death Dis; 2019 May; 10(6):425. PubMed ID: 31142737
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Establishment of a hepatocellular carcinoma cell line with unique metastatic characteristics through in vivo selection and screening for metastasis-related genes through cDNA microarray.
    Li Y; Tang Y; Ye L; Liu B; Liu K; Chen J; Xue Q
    J Cancer Res Clin Oncol; 2003 Jan; 129(1):43-51. PubMed ID: 12618900
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Human mesenchymal stem cells overexpressing pigment epithelium-derived factor inhibit hepatocellular carcinoma in nude mice.
    Gao Y; Yao A; Zhang W; Lu S; Yu Y; Deng L; Yin A; Xia Y; Sun B; Wang X
    Oncogene; 2010 May; 29(19):2784-94. PubMed ID: 20190814
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetically engineered bone marrow-derived mesenchymal stem cells co-expressing IFN-γ and IL-10 inhibit hepatocellular carcinoma by modulating MAPK pathway.
    Wang H; Wang J; Shi X; Ding Y
    J BUON; 2017; 22(6):1517-1524. PubMed ID: 29332347
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination therapy of sorafenib with mesenchymal stem cells as a novel cancer treatment regimen in xenograft models of hepatocellular carcinoma.
    Seyhoun I; Hajighasemlou S; Muhammadnejad S; Ai J; Nikbakht M; Alizadeh AA; Hosseinzadeh F; Mirmoghtadaei M; Seyhoun SM; Verdi J
    J Cell Physiol; 2019 Jun; 234(6):9495-9503. PubMed ID: 30362607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Down-regulation of osteopontin inhibits metastasis of hepatocellular carcinoma cells via a mechanism involving MMP-2 and uPA.
    Chen RX; Xia YH; Xue TC; Zhang H; Ye SL
    Oncol Rep; 2011 Mar; 25(3):803-8. PubMed ID: 21174062
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of bone marrow-derived mesenchymal stromal cells on hepatoma.
    Abd-Allah SH; Shalaby SM; El-Shal AS; Elkader EA; Hussein S; Emam E; Mazen NF; El Kateb M; Atfy M
    Cytotherapy; 2014 Sep; 16(9):1197-206. PubMed ID: 24985939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemically Infused Mesenchymal Stem Cells Show Different Homing Profiles in Healthy and Tumor Mouse Models.
    Xie C; Yang Z; Suo Y; Chen Q; Wei D; Weng X; Gu Z; Wei X
    Stem Cells Transl Med; 2017 Apr; 6(4):1120-1131. PubMed ID: 28205428
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mesenchymal stem cells deliver and release conditionally replicative adenovirus depending on hepatic differentiation to eliminate hepatocellular carcinoma cells specifically.
    Yuan X; Zhang Q; Li Z; Zhang X; Bao S; Fan D; Ru Y; Dong S; Zhang Y; Zhang Y; Ye Z; Xiong D
    Cancer Lett; 2016 Oct; 381(1):85-95. PubMed ID: 27450327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polo-like kinase 1, a new therapeutic target in hepatocellular carcinoma.
    Mok WC; Wasser S; Tan T; Lim SG
    World J Gastroenterol; 2012 Jul; 18(27):3527-36. PubMed ID: 22826617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization and Validation of Hepatocellular Carcinoma (HCC) Xenograft tumor as a Suitable Liver Cancer Model for Preclinical Mesenchymal Stem Cell Studies.
    Hajighasemlou S; Pakzad S; Ai J; Muhammadnejad S; Mirmoghtadaei M; Hosseinzadeh F; Gharibzadeh S; Kamali A; Ahmadi A; Verdi J
    Asian Pac J Cancer Prev; 2018 Jun; 19(6):1627-1631. PubMed ID: 29936790
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ShRNA-targeted centromere protein A inhibits hepatocellular carcinoma growth.
    Li Y; Zhu Z; Zhang S; Yu D; Yu H; Liu L; Cao X; Wang L; Gao H; Zhu M
    PLoS One; 2011 Mar; 6(3):e17794. PubMed ID: 21423629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effect of bear bile powder on STAT3 pathway in hepatocellular carcinoma xenograft].
    Zhao JY; Liu LY; Shen AL; Lin W; Cao ZY; Zhuang QC; Hong ZF
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2014 Aug; 34(8):976-81. PubMed ID: 25223184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemically delivered measles virus-infected mesenchymal stem cells can evade host immunity to inhibit liver cancer growth.
    Ong HT; Federspiel MJ; Guo CM; Ooi LL; Russell SJ; Peng KW; Hui KM
    J Hepatol; 2013 Nov; 59(5):999-1006. PubMed ID: 23867315
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.